Literature DB >> 4593739

An outbreak of streptococcal sore throat and rheumatic fever in a Royal Air Force training camp; significance of serum antibody to M-associated protein.

J P Widdowson, W R Maxted, C W Newrick, D Parkin.   

Abstract

A large outbreak of streptococcal sore throat in a Royal Air Force Training Camp resulted in five cases of rheumatic fever among the 16- to 18-year-old apprentices, and one case in a 33-year-old airman. The most prevalent type of group A streptococcus isolated from throat swabs was M-type 5 and there was serological evidence that at least four of the rheumatic fever (R.F.) cases were due to this type.Among the patients with uncomplicated throat infection the anti-streptolysin O (ASO) and anti-deoxyribonuclease B (anti-DNAase B) responses were in general rather low, even where there was evidence of protective antibody against type 5. However, a combination of the results of the ASO and anti-DNAase B tests gave an estimate of the extent of streptococcal infection 15-25% higher than did either test alone.The titres of antibody to M-associated protein (MAP) were >/= 60 in all the R.F. patients, and in about 50% of the other patients with ASO titres >/= 200. This figure is unusually high compared with data from several other outbreaks of streptococcal infection due to different serotypes and also greatly exceeds comparable figures for cases of sporadic sore throat and acute glomerulonephritis.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4593739      PMCID: PMC2130254          DOI: 10.1017/s0022172400023135

Source DB:  PubMed          Journal:  J Hyg (Lond)        ISSN: 0022-1724


  6 in total

1.  Antistreptolysin-O: its interaction with streptolysin-O, its titration and a comparison of some standard preparations.

Authors:  H GOODER
Journal:  Bull World Health Organ       Date:  1961       Impact factor: 9.408

2.  The use of bacitracin for identifying group A haemolytic streptococci.

Authors:  W R MAXTED
Journal:  J Clin Pathol       Date:  1953-08       Impact factor: 3.411

3.  Streptococcal anti-desoxyribonuclease B: microtechnique determination.

Authors:  J Nelson; E M Ayoub; L W Wannamaker
Journal:  J Lab Clin Med       Date:  1968-05

4.  An M-associated protein antigen (MAP) of group A streptococci.

Authors:  J P Widdowson; W R Maxted; A M Pinney
Journal:  J Hyg (Lond)       Date:  1971-12

5.  Antibody to streptococcal opacity factor in human sera.

Authors:  W R Maxted; J P Widdowson; C A Fraser
Journal:  J Hyg (Lond)       Date:  1973-03

6.  Persistence of type-specific antibodies in man following infection with group A streptococci.

Authors:  R C LANCEFIELD
Journal:  J Exp Med       Date:  1959-08-01       Impact factor: 14.307

  6 in total
  5 in total

1.  Predominance of immunoglobulin G sub-class 3 among the complement-fixing antibodies to streptococcal M-associated protein.

Authors:  G E Mortimer; J P Widdowson
Journal:  Clin Exp Immunol       Date:  1979-08       Impact factor: 4.330

2.  Streptococcal infection in a Junior Detention Centre: a five-year study.

Authors:  A Colling; I Kerr; W R Maxted; J P Widdowson
Journal:  J Hyg (Lond)       Date:  1980-12

3.  Ontogenesis of the formation of secretory antibodies to respiratory syncytial (RS) virus.

Authors:  N P Leschinskaya; E E Pokrovskaya; E A Kantorovitch; S K Grigorjeva
Journal:  Epidemiol Infect       Date:  1988-12       Impact factor: 2.451

Review 4.  Disease manifestations and pathogenic mechanisms of Group A Streptococcus.

Authors:  Mark J Walker; Timothy C Barnett; Jason D McArthur; Jason N Cole; Christine M Gillen; Anna Henningham; K S Sriprakash; Martina L Sanderson-Smith; Victor Nizet
Journal:  Clin Microbiol Rev       Date:  2014-04       Impact factor: 26.132

5.  Enzyme-linked immunosorbent assay for anti-streptococcal protoplast membrane antibodies.

Authors:  N Banchuin; J Wheeler; M Sussman
Journal:  Infection       Date:  1984 Nov-Dec       Impact factor: 3.553

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.